96-Week Results of Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Plus Efavirenz, in Antiretroviral-Naive, HIV-1-infected Adults: ASSERT Study

Antiviral Therapy - United Kingdom
doi 10.3851/imp2667
Full Text
Abstract

Available in full text

Date
Authors
Publisher

International Medical Press

Related search

Abacavir–Lamivudine Versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy

New England Journal of Medicine
Medicine
2009English

Cost-Effectiveness Analysis of Tenofovir/Emtricitabine and Abacavir/Lamivudine in Combination With Efavirenz or Atazanavir/Ritonavir for Treatment-Naive Adults With Hiv-1 Infection in the United Kingdom

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

First-Line Antiretroviral Therapy With Efavirenz Plus Tenofovir Disiproxil Fumarate/Emtricitabine or Rilpivirine Plus Tenofovir Disiproxil Fumarate/Emtricitabine: A Durability Comparison

HIV Medicine
Health PolicyInfectious DiseasesPharmacology
2018English

Early Markers of Tubular Dysfunction in Antiretroviral-Experienced HIV-Infected Patients Treated With Tenofovir Versus Abacavir

AIDS Patient Care and STDs
EnvironmentalPublic HealthInfectious DiseasesOccupational Health
2012English

Differential Effects of Tenofovir/Emtricitabine and Abacavir/Lamivudine on Human Leukocyte Recruitment

Antiviral Therapy
Infectious DiseasesPharmacology
2012English

Patient-Reported Symptoms on the Antiretroviral Regimen Efavirenz/Emtricitabine/Tenofovir

AIDS Patient Care and STDs
EnvironmentalPublic HealthInfectious DiseasesOccupational Health
2012English

Abacavir/Lamivudine Versus Tenofovir/Emtricitabine in Virologically Suppressed Patients Switching From Ritonavir-Boosted Protease Inhibitors to Raltegravir

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2013English

Effects of Highly Active Antiretroviral Therapy on Platelet Activating Factor Metabolism in Naïve HIV-Infected Patients: II) Study of the Abacavir/Lamivudine/Efavirenz Haart Regimen

International Journal of Immunopathology and Pharmacology
AllergyImmunologyPharmacology
2012English

In Vitro Human Immunodeficiency Virus Type 1 Resistance Selections With Combinations of Tenofovir and Emtricitabine or Abacavir and Lamivudine

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy